Fig. 3: Overall survival in (a) 44 patients with PHF6 mutated myelodysplastic syndrome or myelodysplastic /myeloproliferative neoplasm, (b) 36 patients with PHF6 mutated myelodysplastic syndrome stratified by PHF6 mutation variant allele fraction (VAF). | Blood Cancer Journal

Fig. 3: Overall survival in (a) 44 patients with PHF6 mutated myelodysplastic syndrome or myelodysplastic /myeloproliferative neoplasm, (b) 36 patients with PHF6 mutated myelodysplastic syndrome stratified by PHF6 mutation variant allele fraction (VAF).

From: Myeloid neoplasms with PHF6 mutations: context-dependent genomic and prognostic characterization in 176 informative cases

Fig. 3

Kaplan-Meier curves illustrate inferior OS in patients with MDS or MDS/MPN in patients with PHF6 mutation VAF more than 20% at diagnosis.

Back to article page